Cargando…

Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19

Detalles Bibliográficos
Autores principales:	Demaria, Olivier, Carvelli, Julien, Batista, Luciana, Thibult, Marie-Laure, Morel, Ariane, André, Pascale, Morel, Yannis, Vély, Frederic, Vivier, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327215/ https://www.ncbi.nlm.nih.gov/pubmed/32612152 http://dx.doi.org/10.1038/s41423-020-0493-9

Ejemplares similares

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
por: Carvelli, Julien, et al.
Publicado: (2020)

S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS
por: Demaria, Olivier, et al.
Publicado: (2023)

The Role of Natural Killer Cells in Sepsis
por: Chiche, Laurent, et al.
Publicado: (2011)

Phenotype and Functions of Natural Killer Cells in Critically-Ill Septic Patients
por: Forel, Jean-Marie, et al.
Publicado: (2012)

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013)

Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection?
por: Dap, Matthieu, et al.
Publicado: (2020)

Severe peripheral blood lymphopenia without NK cell cytotoxicty deficiency is the rule in adult acquired HLH
por: Carvelli, J, et al.
Publicado: (2015)

Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
por: Mariotti, F.R., et al.
Publicado: (2020)

ChatGPT: the next frontier in academic writing for cardiologists or a pandora’s box of ethical dilemmas
por: Marchandot, Benjamin, et al.
Publicado: (2023)

Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency
por: Ebbo, Mikael, et al.
Publicado: (2016)

Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock
por: Carvelli, Julien, et al.
Publicado: (2019)

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
por: André, Pascale, et al.
Publicado: (2018)

Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
por: Buckle, Irina, et al.
Publicado: (2021)

Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*
por: Carvelli, Julien, et al.
Publicado: (2022)

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
por: Demaria, Olivier, et al.
Publicado: (2022)

Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia
por: Crinier, Adeline, et al.
Publicado: (2020)

Cough syrups: silent killer of Gambian children
por: Chopra, Hitesh, et al.
Publicado: (2023)

Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123
por: Gauthier, Laurent, et al.
Publicado: (2023)

Road Traffic Accidents The Number One Killer in Libya
por: Ahmed Ali, Abdulmajid
Publicado: (2007)

Natural killer cell-based therapies
por: Romagné, François, et al.
Publicado: (2011)

Bringing natural killer cells to the clinic
por: Chiossone, Laura, et al.
Publicado: (2022)

T cell regulation of natural killer cells
por: Kerdiles, Yann, et al.
Publicado: (2013)

Neurolymphomatosis Caused by Nasal-type Extranodal Natural Killer/T-cell Lymphoma
por: Yi, Fang-Fang, et al.
Publicado: (2017)

Natural Killer Cells: From Basic Research to Treatments
por: Vivier, Eric, et al.
Publicado: (2011)

OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases
por: Thiele, Michael, et al.
Publicado: (2022)

Primary Cutaneous Extranodal Natural Killer (NK) T-Cell Lymphoma: A Case Report
por: Zhang, Si, et al.
Publicado: (2023)

How to use immune checkpoint inhibitor in ovarian cancer?
por: Park, Junsik, et al.
Publicado: (2019)

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2022)

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
por: Walia, Anushka, et al.
Publicado: (2023)

Subtractive sequence analysis aided druggable targets mining in Burkholderia cepacia complex and finding inhibitors through bioinformatics approach
por: Hassan, Syed Shah, et al.
Publicado: (2022)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

Immune checkpoints on innate lymphoid cells
por: Chiossone, Laura, et al.
Publicado: (2017)

A Rapidly Progressing Fatal Case of Natural Killer/T-Cell Lymphoma Presenting as Orbital Inflammation
por: Tang, Guang-Min, et al.
Publicado: (2018)

Differential diagnosis of pseudohypopyon and discussion of Extranodal natural killer/T-cell lymphoma presenting as hypopyon panuveitis
por: Evereklioglu, Cem
Publicado: (2022)

Reply to: differential diagnosis of pseudohypopyon and discussion of extranodal natural killer/T-cell lymphoma presenting as hypopyon panuveitis
por: Sukon, Nutchaya, et al.
Publicado: (2022)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Inhibitory Influence of Chronic Amœbiasis on Immunity against Bacterial Infection
por: Ghosh, H.
Publicado: (1939)

Comment on ‘Toxicities associated with immune checkpoint inhibitors: A systematic study’
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2023)

Monalizumab: inhibiting the novel immune checkpoint NKG2A
por: van Hall, Thorbald, et al.
Publicado: (2019)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eef2ec1m9hifu959kq9eul3ssg